A corner of the cancer therapy market is heating up—Here are the names investors need to know
Radiopharmaceuticals seek to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly into the tumor.
Radiopharmaceuticals seek to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly into the tumor.
